European equities traded in the US as American depositary receipts started the week higher late Monday morning, rising 0.51% to 1,900.39 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by medical device maker EDAP TMS (FOCL) and telecommunications company Nokia (NOK), which rose 4.9% and 3.9% respectively. They were followed by biopharmaceutical companies Grifols (GRFS) and Cellectis (CLLS), which increased 3.7% and 1.8% respectively.
The decliners from continental Europe were led by and biotech firm Evaxion (EVAX) and lender Banco Santander (SAN), which fell 17% and 4% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and brewing company Anheuser-Busch InBev (BUD), which dropped 3% and 2.7% respectively.
The gainers from the UK were led by hospitality company InterContinental Hotels Group (IHG) and biopharmaceutical company NuCana (NCNA), which advanced 4.1% and 2.9% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and lender Barclays (BCS), which were up 2.7% and 2.2% respectively.
The decliners from the UK and Ireland were led by software firm Endava (DAVA) and oil and gas company BP (BP), which lost 1.4% and 1.3% respectively. They were followed by oil and gas company Shell (SHEL) and alcoholic beverage company Diageo (DEO), which were down 1.2% and 1.1% respectively.
Comments